Literature DB >> 25231028

Crystal structure, DFT, spectroscopic and biological activity evaluation of analgin complexes with Co(ii), Ni(ii) and Cu(ii).

Ahmed M Mansour1.   

Abstract

Reaction of analgin (NaL) with Co(ii), Ni(ii) and Cu(ii) salts in ethanol affords complexes of the type [ML2], which were characterized by elemental analysis, FT IR, UV-Vis, EPR, TG/DTA, magnetic susceptibility and conductance measurements. The copper(ii) complex crystallizes in the orthorhombic Pbca space group. Analgin behaves as a mono-negatively tridentate ligand via pyrazolone O, sulfonate O and tertiary amino groups. The interaction of the tertiary nitrogen with M(n+) ions is the main factor which determines the stability of complexes as revealed from natural bond orbital analysis data, where the binding energy of [ML2] decreases with an increase in the bond length of the M-N bond. Time-dependent density functional theory calculations were applied in order to realize the electronic structures and to explain the related experimental observations. The anti-bacterial activity was studied on Staphylococcus aureus and Escherichia coli. Coordination of analgin to Ni(ii) and Cu(ii) leads to a significant increase in its antibacterial activity as compared with the Co(ii) complex.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25231028     DOI: 10.1039/c4dt02366h

Source DB:  PubMed          Journal:  Dalton Trans        ISSN: 1477-9226            Impact factor:   4.390


  2 in total

1.  DNA/lysozyme binding propensity and nuclease properties of benzimidazole/2,2'-bipyridine based binuclear ternary transition metal complexes.

Authors:  Ahmed M Mansour; Mona S Ragab
Journal:  RSC Adv       Date:  2019-09-30       Impact factor: 4.036

2.  Fluorogenic Detection of Sulfite in Water by Using Copper(II) Azacyclam Complexes.

Authors:  Carlo Ciarrocchi; Donatella Sacchi; Massimo Boiocchi; Maduka Lankani Weththimuni; Alessio Orbelli Biroli; Maurizio Licchelli
Journal:  Molecules       Date:  2022-03-12       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.